Back
Recursion Pharmaceuticals Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
RXRX
Recursion Pharmaceuticals
Last Price:
5.80
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Recursion Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 30.8% based on the past 3 years of stock performance.
- Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Recursion Pharmaceuticals Stock Undervalued?
The current Recursion Pharmaceuticals [RXRX] share price is $5.75. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 30.8% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
44
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
- Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
15.74
52-Week Low:
5.62
Prediction Charts
Market Cap:
1.65B
Price in USD:
5.75
Volume:
12.27M
Beta:
0.81
Technical Analysis
SMA50:
6.63
SMA100:
6.95
SMA200:
8.34
52-Wk Change:
-12.08%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?
Yes, Recursion Pharmaceuticals is a publicly traded company. -
What is the Recursion Pharmaceuticals stock quote today?
The Recursion Pharmaceuticals stock price is 5.75 USD today. -
How to buy Recursion Pharmaceuticals stock online?
You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 6.40 | 6.62 | 6.69 | 6.22 |
| Nov-5 | 6.59 | 6.82 | 6.83 | 6.47 |
| Nov-6 | 6.95 | 6.97 | 7.05 | 6.77 |
| Nov-7 | 6.92 | 6.93 | 7.09 | 6.68 |
| Nov-8 | 6.86 | 7.10 | 7.21 | 6.81 |
| Nov-11 | 7.50 | 7.84 | 8.49 | 7.23 |
| Nov-12 | 7.52 | 7.58 | 8.05 | 7.43 |
| Nov-13 | 7.80 | 7.31 | 8.04 | 7.31 |
| Nov-14 | 7.39 | 6.91 | 7.58 | 6.88 |
| Nov-15 | 6.89 | 6.18 | 6.92 | 6.15 |
| Nov-18 | 6.25 | 6.10 | 6.26 | 5.90 |
| Nov-19 | 6.01 | 6.27 | 6.33 | 5.84 |
| Nov-20 | 6.30 | 6.04 | 6.37 | 5.70 |
| Nov-21 | 6.02 | 5.75 | 6.03 | 5.62 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.